American Journal of Kidney Diseases
Volume 56, Issue 1 , Pages 157-167 , July 2010

The Pathogenesis of Idiopathic Membranous Nephropathy: A 50-Year Odyssey

  • Richard J. Glassock, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Richard J. Glassock, MD, 8 Bethany, Laguna Niguel, CA

References 

  1. Jones D. Nephrotic glomerulonephritis. Am J Pathol. 1957;33:313–329
  2. Beck LH, Bonegio RG, Lambeau G, et al. M-Type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11–21
  3. Kerjaschki D. Pathomechanisms and molecular basis of membranous nephropathy. Lancet. 2004;364:1194–1196
  4. Glassock RJ. Secondary membranous nephropathy. Nephrol Dial Transplant. 1992;7(suppl 1):S64–S71
  5. Bell ET. Renal Diseases. In: Philadelphia, PA: Lea & Febiger; 1946;p. 141–253
  6. Ellis A. Natural history of Bright's disease (Clinical, histological and experimental observations). Lancet. 1942;1:1–7
  7. Movat HZ, McGregor DD. The fine structure of the glomerulus in membranous glomerulonephritis (lipoid nephrosis) in adults. Am J Clin Pathol. 1959;32:100–127
  8. Farquhar M, Vernier R, Good R. An electron microscope study of the glomerulus in nephrosis, glomerulonephritis and lupus erythematosus. J Exp Med. 1957;106:649–660
  9. Mellors RC, Ortega LG, Holman HR. Role of gammaglobulins in pathogenesis of renal lesions in systemic lupus erythematosus and chronic membranous glomerulonephritis, with an observation of the lupus erythematosus cell reaction. J Exp Med. 1957;1065:191–202
  10. Coons AH, Kaplan MH. Localization of antigen in tissue cells; improvements in a method for the detection of antigen by means of fluorescent antibody. J Exp Med. 1950;91:1–13
  11. Heymann W, Hackel DB, Harwood S, Wilson SG, Hunter JL. Production of nephrotic syndrome in rats by Freund's adjuvant and rat kidney suspensions. Proc Soc Exp Biol Med. 1959;100:660–664
  12. Hunter JL, Hackel DB, Heymann W. Nephrotic syndrome in rats produced by sensitization to rat kidney proteins: immunologic studies. J Immunol. 1960;85:319–327
  13. Dixon FJ, Feldman J, Vasquez JJ. Experimental glomerulonephritis (The pathogenesis of a laboratory model resembling human glomerulonephritis). J Exp Med. 1961;113:899–920
  14. Dixon FJ. The role of antigen-antibody complexes in disease. Harvey Lectures. 1963;58:21–52
  15. Agadoa LM, Gauthier VJ, Mannik M. Precipitating antigen-antibody systems are required for the formation of subepithelial electron dense immune deposits. J Exp Med. 1983;158:1259–1271
  16. Mannik M. Mechanisms of tissue deposition of immune complexes. J Rheumatol Suppl. 1987;13:35–42
  17. Feenstra H, van den Lee R, Greben HA, Arends A, Hoedemaeker PJ. Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens (I. The natural history: a histologic and immunohistologic study at the light microscopic and the ultrastructural level). Lab Invest. 1975;32:235–242
  18. Fleuren GJ, Lee R, Greben HA, Van Damme BJ, Hoedemaeker PJ. Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens (IV. Investigations into the pathogenesis of the model). Lab Invest. 1978;38:496–501
  19. Edgington TS, Glassock RJ, Dixon FJ. Autologous immune complex nephritis induced with renal tubular antigen: I (Identification and isolation of the pathogenetic antigen). J Exp Med. 1968;127:555–572
  20. Glassock RJ, Watson JI, Edgington TS, Dixon FJ. Autologous immune complex glomerulonephritis (III. Studies on cellular and parabiotic transfer). J Immunol. 1969;102:194–205
  21. Hess EV, Ashworth CT, Ziff M. Transfer of an autoimmune nephrosis in the rat by means of lymph node cells. J Exp Med. 1962;115:421–438
  22. Stenglein B, Thoenes GH, Gunther E. Genetically controlled autologous immune complex glomerulonephritis in rats. J Immunol. 1975;115:895–897
  23. Edgington TS, Glassock RJ, Dixon FJ. Autologous immune-complex pathogenesis of experimental allergic glomerulonephritis. Science. 1967;155:1432–1437
  24. Glassock RJ, Edgington TS, Watson JI, Dixon FJ. Autologous immune complex nephritis induced with renal tubular antigen (II. The pathogenetic mechanism). J Exp Med. 1968;127:573–588
  25. Van Damme BJ, Fleuren GJ, Bakker WW, Vernier RL, Hoedemaeker PJ. Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens (V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis). Lab Invest. 1978;38:502–510
  26. Couser WG, Steinmuller DR, Stilmant MM, Salant DJ, Lowenstein LM. Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest. 1978;62:1275–1287
  27. Okuda R, Kaplan MH, Cuppage FE, Heymann W. Deposition of autologous gamma globulin in kidneys of rats with nephrotic renal disease of various etiologies. J Lab Clin Med. 1965;66:204–215
  28. Makker SP, Moorthy B. In situ immune complex formation in isolated perfused kidney using homologous antibody. Lab Invest. 1981;44:1–5
  29. Makker SP, Widstrom R, Huang J. Transcription and translation of gp600 and receptor-associated protein (RAP) in active Heymann nephritis. Am J Pathol. 1995;146:1481–1487
  30. Makker SP. Evidence that the antigen of autologous immune complex glomerulonephritis of rats is a mannose or glucose-containing glycoprotein. Proc Soc Exp Biol Med. 1980;163:95–99
  31. Kerjaschki D, Farquhar MG. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci U S A. 1982;79:5557–5561
  32. Makker SP, Singh AK. Characterization of the antigen (gp600) of Heymann nephritis. Lab Invest. 1984;50:287–293
  33. Farquhar MG, Saito A, Kerjaschi D, Orlando RA. The Heymann nephritis antigen complex: megalin (gp330) and RAP. J Am Soc Nephrol. 1995;6:35–47
  34. Huang J, Makker S. Role of receptor-associated 39/45 kD protein in active Heymann nephritis. Kidney Int. 1995;47:432–441
  35. Olienikov AV, Feliz BJ, Makker SP. A small N-terminal 60-kD fragment of gp600 (megalin), the major auto-antigen of active Heymann nephritis, can induce a full-blown disease. J Am Soc Nephrol. 2000;11:57–64
  36. Ronco P, Debiec H. Molecular dissection of target antigens and nephritogenic antibodies in membranous nephropathy: towards epitope-driven therapies. J Am Soc Nephrol. 2006;17:1772–1774
  37. Tramontano A, Knight T, Vizzuso D, Makker SP. Nested N-terminal megalin fragments induce high-titer autoantibody and attenuated nephritis. J Am Soc Nephrol. 2006;17:1979–1985
  38. Tramontano A, Makker SP. Conformation and glycosylation of a megalin fragment correlates with nephritogenicity in Heymann nephritis. J Immunol. 2004;172:2367–2373
  39. Shah P, Tramontano A, Makker SP. Intramolecular epitope spreading in Heymann nephritis. J Am Soc Nephrol. 2007;18:3060–3066
  40. Batsford S, Oite T, Takamiya H, Vogt A. Anionic binding sites in the glomerular basement membrane: possible role in the pathogenesis of immune complex glomerulonephritis. Ren Physiol. 1980;3:336–340
  41. Border WA, Kamil ES, Ward HJ, Cohen AH. Antigenic changes as a determinant of immune complex localization in the rat glomerulus. Lab Invest. 1981;45(5):442–449
  42. Bariety J, Druet P, Laliberte F, Sapin C. Glomerulonephritis with γ and β1c deposits induced in rats by mercuric chloride. Am J Pathol. 1971;85:293–302
  43. Lewis EJ, Bolton WK, Spargo B, Stuart FJ. Persistent proteinuria in the rat with Heymann nephritis [abstract]. Clin Res. 1971;20:763
  44. Makker SP, Kanalas JJ. Course of transplanted Heymann nephritis kidney into a normal host: implications for mechanism of proteinuria in membranous glomerulonephropathy. J Immunol. 1989;142:3406–3410
  45. Pruchno CJ, Burns M, Schultze M, et al. Urinary excretion of the C5b-C9 membrane attack complex of complement is marker of immune disease activity in autologous immune complex nephritis. Am J Pathol. 1991;138:203–211
  46. Salant DJ, Belok S, Madaio MP, Couser WG. A new role for complement in experimental membranous nephropathy in rats. J Clin Invest. 1980;66(6):1339–1350
  47. Makker SP, Tramontano A. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis—implications for the pathogenesis of idiopathic membranous glomerulonephritis. J Pathol. 2006;210:282–287
  48. Sugisaki T, Klassen J, Andres GA, Milgrom F, McCluskey RT. Passive transfer of Heymann nephritis with serum. Kidney Int. 1973;3:66–73
  49. van Es LA, Blok AP, Schonfield L, Glassock RJ. Chronic nephritis induced by antibodies reacting with glomerular bound immune complexes. Kidney Int. 1977;11:106–115
  50. Kerjaschki D, Neale TJ. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis). J Am Soc Nephrol. 1996;7:2518–2526
  51. Neale TJ, Ojha PP, Exner M, et al. Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen. J Clin Invest. 1994;94:1577–1584
  52. Cybulsky AV, Quigg RJ, Salant DJ. Experimental membranous nephropathy redux. Am J Physiol Renal Physiol. 2005;289:F660–F671
  53. Klassen J, Sugisaki T, Milgrom F, McCluskey RT. Studies on multiple renal lesions in Heymann nephritis. Lab Invest. 1971;25:577–585
  54. Cunningham PN, Hack BK, Ren G, Minto AW, Morgan BP, Quigg RJ. Glomerular complement regulation is overwhelmed in passive Heymann nephritis. Kidney Int. 2001;60(3):900–909
  55. Spicer TS, Tran GT, Killingsworth MC, et al. Induction of passive Heymann nephritis in complement 6-deficient PVG rats. J Immunol. 2007;179:172–178
  56. Leenaerts PL, Hall BM, van Damme BJ, Daha MR, Vanrenterghem YF. Active Heymann nephritis in complement component C6 deficient rats. Kidney Int. 1995;47:1604–1614
  57. Penny MJ, Boyd RA, Hall BM. Permanent CD8+ T cell depletion prevents proteinuria in active Heymann nephritis. J Exp Med. 1998;188:1775–1784
  58. Salant DJ, Cappaerll N, Madaio MP, Darby CM, Stillmant MM, Couser WG. Altered glomerular permeability induced by F(Ab)2 and FAb′ antibodies to rat renal tubular epithelial antigen. Kidney Int. 1998;21:36–43
  59. Neale TJ, Couser WG, Salant DJ, Lowenstein LM, Wilson CB. Specific uptake of Heymann's nephritic kidney eluate by rat kidney: studies in vivo and in isolated perfused kidneys. Lab Invest. 1982;46:450–453
  60. Schultze M, Pruchno CJ, Burns M, Baker PJ, Johnson RJ, Couser WG. Glomerular localization of C3c indicates on-going immune deposit formation and complement activation in experimental glomerulonephritis. Am J Pathol. 1993;142:179–187
  61. Whitworth JA, Leibowitz S, Kennedy MC, et al. Absence of glomerular renal tubular epithelial antigen in membranous glomerulonephritis. Clin Nephrol. 1976;5:159–162
  62. Pardo V, Strauss J, Kramer H, Ozawa T, McIntosh RM. Nephropathy associated with sickle cell anemia: an autologous immune complex nephritis (II. Clinicopathologic study of seven patients). Am J Med. 1975;59:650–659
  63. Debiec H, Guigonis V, Mougenot B, et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med. 2002;346:2053–2060
  64. Ronco P, Debiec H. Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men. Semin Immunopathol. 2007;29:445–458
  65. Debiec H, Nauta J, Coulet F, et al. Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies. Lancet. 2004;364:1252–1259
  66. Glassock RJ. Human idiopathic membranous nephropathy—a mystery solved?. N Engl J Med. 2009;361:81–83
  67. Doi T, Mayumi M, Kanatsu K, Suehiro F, Hamashima Y. Distribution of IgG subclasses in membranous nephropathy. Clin Exp Immunol. 1984;58:57–62
  68. Kuroki A, Shibata T, Honda H, Totsuka D, Kobayashi K, Sugisaki T. Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis and idiopathic membranous nephropathy. Intern Med. 2002;41:936–942
  69. Ohtani H, Wakui H, Komatsuda A, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant. 2004;19:574–579
  70. Haas M. IgG subclass deposits in glomeruli of lupus and non-lupus membranous nephropathies. Am J Kidney Dis. 1994;23:358–363
  71. Oliveira DBG. Membranous nephropathy: an IgG4 mediated disease. Lancet. 1998;351:670–671
  72. Shimizu S, Sugiyama N, Masutani K, et al. Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for Il-27 receptor (WSX-1). J Immunol. 2005;175:7185–7192
  73. Ruggenenti P, Cravedi P, Sghirlanzoni MC, et al. Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy. Clin J Am Soc Nephrol. 2008;3:1652–1659
  74. Kon SP, Coupes B, Short CD, et al. Urinary C5b-C9 excretion and clinical course in idiopathic human membranous nephropathy. Kidney Int. 1995;48:1953–1958
  75. Schultze M, Donadio JP, Pruchno CJ, et al. Elevated urinary excretion of the C5b-C9 complex in membranous nephropathy. Kidney Int. 1991;40:533–588

 Originally published online as doi:10.1053/j.ajkd.2010.01.008 on April 9, 2010.

PII: S0272-6386(10)00038-7

doi: 10.1053/j.ajkd.2010.01.008

American Journal of Kidney Diseases
Volume 56, Issue 1 , Pages 157-167 , July 2010

Article Tools

* Image Usage & Resolution